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Dear Editor:
We present the images of a young patient with well-differ-
entiated thyroid carcinoma who had mediastinal I-131 up-
take on first posttherapy radioiodine scintigraphy,
diagnosed as thymus gland activity on hybrid single photon
emission computed tomography (SPECT=CT) imaging. This
relatively new technology allows rapid and precise locali-
zation of I-131 activity to anatomic structures, which in this
patient confirmed a known physiologic mimic of disease,
allowing conservative management.
An 11-year-old girl was diagnosed with papillary thyroid
carcinoma on fine-needle aspiration biopsy, after presenting
with a left-sided neck mass. Thyroid ultrasound revealed a
4 cm left thyroid lobe mass and several nearby cervical lymph
nodes with microcalcifications suspicious for nodal metasta-
ses. She underwent total thyroidectomy and lymph node
dissection of the central neck compartment (pTNM stage 1).
She was referred to our Nuclear Medicine Therapy Clinic 2
months later for assessment for radioiodine therapy. Her
biochemical markers at the time were thyroid-stimulating
hormone 355 mU=L, thyroglobulin (Tg) < 0.5 ng=mL, and
anti-Tg antibodies present. Histopathology reported evi-
dence for capsular invasion of the thyroid cancer with extra-
thyroidal extension and 14=24 lymph nodes in the central
compartment positive for metastases. The patient was
otherwise healthy with no intercurrent illness and a normal
chest radiograph.
Diagnostic scintigraphy with 37 MBq (1 mCi) I-131 dem-
onstrated intense radioiodine uptake in the central neck
compartment with no abnormal uptake in the thorax. An
oral dose of 5.7 GBq (155 mCi) I-131 was administered. On
the posttherapy images 4 days later there was thoracic
radioiodine uptake in an inverted V-shape suggestive of
thymic uptake (Fig. 1). Intense radioiodine uptake in the
central neck was consistent with local cervical nodal metas-
tases. Also present was diffuse hepatic radioiodine uptake,
due to residual functioning thyroid tissue incorporating I-131
into thyroxine, which was subsequently metabolized in the
liver.
Thoracic SPECT=CT imaging was performed on a gamma
camera with inline CT capability (Symbia T6; Siemens
Medical Solutions, Illinois) to further evaluate the mediasti-
nal I-131 activity (Fig. 2). Fusion axial and coronal images
localized thoracic radioiodine activity to a bilobed anterior
mediastinal soft tissue density consistent with the thymus in
this young patient. SPECT=CT technology allowed a rapid
clinical answer, with greater confidence than planar images,
and obviated the need for diagnostic thoracic CT. The patient
was staged as T4, N1, and M0 due to histopathologic evi-
dence of capsular extension and central compartment lymph
nodes positive for disease. The presence of anti-Tg antibodies
in serum invalidated the undetectable Tg levels; however,
based on SPECT=CT appearance, mediastinal nodal or thy-
mic metastases were considered unlikely and biopsy was not
performed. The patient had no identifiable clinical reason for
thymic hyperplasia.
Radioiodine uptake in the thymus of young patients
with differentiated thyroid cancer is a known physiologic
mimic of disease, which can be managed conservatively (1).
Recently, identification of sodium–iodine symporter gene
expression in extrathyroidal tissue, including thymus, pro-
vides indirect evidence for the mechanism of uptake (2). The
incidence of thymus visualization on I-131 scintigraphy has
been reported between 3.4% and 26.3% in four series, the
largest with 489 patients by Haveman et al. (3). They sug-
gested a flow chart to assist management of patients with
mediastinal activity. I-131 SPECT=CT imaging has been
shown to provide superior lesion localization and more ac-
curate staging of thyroid cancer (4). Certainly, SPECT=CT
could aid work-up of mediastinal activity by characterizing
uptake as physiologic (including esophageal secretions,
gastro-esophageal reflux, hiatus hernia, thymus, and tra-
cheo-bronchial aspiration) or pathologic (mediastinal nodal,
pulmonary, or osseus metastases) and guide management.
Gamma cameras with integrated CT have the advan-
tages of rapid, efficient, fusion of functional and anatomic
data, with minimal patient motion between acquisitions. The
CT portion of the study is typically low dose and non-
diagnostic, performed for localization and attenuation cor-
rection purposes only. Therefore, the radiation dose is
lower than diagnostic CT. Hybrid SPECT=CT imaging is a
new tool at the nuclear physician’s disposal that improves
staging of thyroid cancer, although its use should be ju-
dicious in the pediatric population (5). An alternative to
evaluate suspected thymic tissue is to perform MR imaging,
which has the significant advantage of avoiding ionizing
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radiation exposure in younger patients. The normal thy-
mus gland characteristically will have a homogenous T2 or
short TI inversion recovery (STIR) signal, although if the
thymic mass contains fat, chemical-shift MR sequences have
been found useful in early adulthood populations, in dif-
ferentiating thymic hyperplasia from tumors of the thymus
gland (6).
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FIG. 1. Posttherapy I-131 anterior static image of the neck
and thorax demonstrates mild radioiodine uptake in the
anterior thorax with an inverted V-shape suggestive of thy-
mic gland activity (arrows). Central neck radioiodine uptake
is consistent with cervical nodal metastases.
FIG. 2. Posttherapy I-131 fusion SPECT=CT (A) axial and (B) coronal images localize thoracic radioiodine activity to a
bilobed anterior mediastinal soft tissue density consistent with thymus in this young girl (arrows).
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